Maria Antonia Berrios
- Democratic
Primary
Urges the Congress of the United States to help ensure that any new legislation allowing for approval of biosimilar drugs includes provisions to ensure that the public health is protected by adequate testing of biosimilar products and physician control over which treatments their patients receive, and that the legislation preserves the ability to create innovative and important new biotechnology therapies.
No votes to display
Session Sine Die
Rule 19(b) / Re-referred to Rules Committee
Assigned to Bio-Technology Committee
Referred to Rules Committee
Filed with the Clerk by Rep. Maria Antonia Berrios
| Bill Text Versions | Format |
|---|---|
| Introduced | HTML |
| Document | Format |
|---|---|
| No related documents. |
Data on Open States is updated periodically throughout the day from the official website of the Illinois General Assembly.
If you notice any inconsistencies with these official sources, feel free to file an issue.